Gelteq Limited (NASDAQ:GELS – Get Free Report) shares were up 1.4% during mid-day trading on Tuesday . The stock traded as high as $1.07 and last traded at $1.06. Approximately 10,157 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 182,839 shares. The stock had previously closed at $1.05.
Gelteq Trading Up 1.4 %
The company has a fifty day moving average of $1.88.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Gelteq stock. Citadel Advisors LLC bought a new position in Gelteq Limited (NASDAQ:GELS – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 23,748 shares of the company’s stock, valued at approximately $55,000. Citadel Advisors LLC owned about 0.25% of Gelteq as of its most recent SEC filing.
Gelteq Company Profile
Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition.
See Also
- Five stocks we like better than Gelteq
- Quiet Period Expirations Explained
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Growth Stocks: What They Are, What They Are Not
- NVIDIA Insiders Sell: This Is What It Means for the Market
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Gelteq Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gelteq and related companies with MarketBeat.com's FREE daily email newsletter.
